Apoptosis served on an origami plate
Cancer is the leading cause of death worldwide, with metastasizing cancer types accounting for roughly 90 % of cancer deaths. Traditional chemotherapeutics target all rapidly dividing cells, which often causes severe toxic effects on the organism, as well as drug resistance in many patients. The development of targeted therapeutics is therefore of great interest, as this allows higher local concentration of drugs at the desired tissue, thus lowering side effects.
The aim of our project is to design, synthesize and test a nano drug that is specifically activated by cancer cells and can induce apoptosis in these cells. The system is designed based on the DNA origami method, in which a long, single stranded plasmid DNA is folded into a large 3D structure.
The overall design consists of a two-layered origami plate to which the active components of the drug is attached (Figure 1A). To protect the active components during the transport, a dome-shaped origami is attached on top of the plate (Figure 1B). The dome is attached to the plate through a peptide sequence which is specifically recognized and cleaved by an extracellular matrix degrading enzyme, matrix metalloprotease 2 (MMP2). This enzyme is overexpressed in some types of metastasizing cancer cells, and this enables the drug to very specifically open and activate the system in close proximity to these cells.
Goals for the project
SITEMAP | BIOMOD 2013 NANO CREATORS | Aarhus University
Copyright (C) 2013 | BIOMOD Team Nano Creators @ Aarhus University | Programming by: Peter Vium Skaarup.